DGAT1 and prostate carcinoma: EPHB2 acts as EPHB2, a suppressor of prostate cancer cells, is able to exert its tumor suppressive effect by inhibiting the activity of lipogenic factors DGAT1, DGAT2 and promoting the lipolytic factor ATGL, PEDF (7).